Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
332.78
+2.63 (+0.80%)
Streaming Delayed Price
Updated: 12:32 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
43
44
Next >
Amgen Q2 Earnings and Revenues Beat Estimates
August 04, 2022
Amgen came out with quarterly earnings of $4.65 per share.
Via
Talk Markets
What Are Whales Doing With Amgen
August 04, 2022
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx
August 04, 2022
The company also reported a second-quarter beat and reiterated its earnings outlook.
Via
Investor's Business Daily
Recap: Amgen Q2 Earnings
August 04, 2022
Amgen (NASDAQ:AMGN) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by 5.68%,...
Via
Benzinga
ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why
August 04, 2022
Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?
Via
Benzinga
ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash
August 04, 2022
ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of
Via
Spotlight Growth
ChemoCentryx Stock More Than Doubles On $4B Buyout
August 04, 2022
Via
Benzinga
HC Wainwright Is Bullish On DICE Therapeutics - Read Why
July 18, 2022
Via
Benzinga
ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition
August 04, 2022
ChemoCentryx (CCXI) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (AMGN).
Via
InvestorPlace
Amgen Plans $3.7 Billion ChemoCentryx Buyout, Tapping Into A New Market
August 04, 2022
The company will pay $52 per share to buy ChemoCentryx, a rare disease-focused firm.
Via
Investor's Business Daily
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Oil Falls Amid Rise In Reserves, China Is Creating A Blockade On Taiwan
August 04, 2022
Crude oil inventories unexpectedly rose by 4.5 million barrels last week, compared to analysts' forecast of 600,000 barrels. The OPEC+ group said it would raise its oil production target by just...
Via
Talk Markets
Equity Index Futures Rebound Despite Concerns Over OPEC And China
August 03, 2022
(Wednesday Market Open) Stocks look to rebound as equity index futures point to a higher open and the dollar retreats from yesterday’s rally. But Fed speak and news out of OPEC and China present...
Via
Benzinga
Don’t Mess With The IRS
August 02, 2022
If we've learned anything from the likes of Al Capone, it’s that you don’t want to mess with the IRS. That’s especially true when Amgen may be the first target in an aggressive campaign to clamp down...
Via
Talk Markets
10 Highest Yielding Dow Jones Stocks: Which Stocks Pay Out 3.2% To 5.5% To Investors?
August 02, 2022
Created in 1896 by Charles Dow, the Dow Jones Industrial Average is one of the oldest and most followed equity indexes for overall stock market health. The Dow Jones Industrial Average consists of 30...
Via
Benzinga
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now
August 02, 2022
(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open....
Via
Benzinga
Is The Energy Ready To Rebound?
August 01, 2022
(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs.
Via
Benzinga
Benzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not Shut Facebook Services And Other Top Financial Stories Monday, August 1
August 01, 2022
CNBC
Via
Benzinga
Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report
August 01, 2022
Via
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...
Via
Benzinga
Big Tech Continues To Rally Despite Earnings Misses
July 29, 2022
(Friday Market Open) Equity index futures pointed to a higher open as investors looked to wrap up the week and month on a positive note, but a higher-than-expected inflation report pushed the dollar...
Via
Benzinga
Meta and Qualcomm Miss— Will Tech Investors Shrug Off These Reports Too?
July 28, 2022
(Thursday Market Open) Investors might be ready to take a breather after yesterday’s Fed rate rally, but with slower second-quarter GDP numbers and even more earnings and global economic data arriving...
Via
Benzinga
Should You Buy AbbVie Ahead Of Earnings?
July 28, 2022
AbbVie (NYSE: ABBV) is due to announce its earnings over the next couple of days. Some investors are considering buying it in advance, but it is worth the investment?
Via
MarketBeat
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
July 27, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 4.3% on an annualized basis producing an average annual return of 11.17%. Currently, Amgen has a market capitalization of...
Via
Benzinga
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
Via
Benzinga
Trustworthy Companies Offer Superior Investment Returns With Less Risk
July 25, 2022
When companies (and the investment community) turn their attention to the long-term benefits of trust, great things happen.
Via
Talk Markets
Dow Jones Giant Amgen Leads 5 Stocks To Watch Near Buy Points
July 23, 2022
Dow Jones giant Amgen headlines five stocks to watch setting near buy points or key support levels that may offer early entries.
Via
Investor's Business Daily
Dividend Income Update June 2022
July 22, 2022
Let’s take a look back at my June 2022 dividend income.
Via
Talk Markets
7 Best Pharmaceutical Stocks to Buy Now
July 20, 2022
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.
Via
InvestorPlace
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
July 15, 2022
The group has several commonalities, including strong ratings and promising charts.
Via
Investor's Business Daily
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.